Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Oral testing for sulfite asthma]

H Hein1, D Kirsten, R A Jörres

  • 1Krankenhaus Grosshansdorf, Zentrum für Pneumologie und Thoraxchirurgie, Grosshansdorf.

Pneumologie (Stuttgart, Germany)
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship between T90 and systemic hypertension in patients with obstructive sleep apnea: Data from the European sleep apnea database.

European journal of internal medicine·2026
Same author

[Linguistic Validation of the "German Lung Fibrosis Health Related Quality of Life Questionnaire"].

Pneumologie (Stuttgart, Germany)·2021
Same author

[Management of diagnostic procedures and treatment of sleep related breathing disorders in the context of the coronavirus pandemic].

Somnologie : Schlafforschung und Schlafmedizin = Somnology : sleep research and sleep medicine·2020
Same author

[Management of Diagnostic Procedures and Treatment of Sleep Related Breathing Disorders in the Context of the Coronavirus Pandemic - German Respiratory Society (DGP), German Sleep Society (DGSM)].

Pneumologie (Stuttgart, Germany)·2020
Same author

Hyperlipidaemia prevalence and cholesterol control in obstructive sleep apnoea: Data from the European sleep apnea database (ESADA).

Journal of internal medicine·2019
Same author

[DGP Interstitial Lung Disease Patient Questionnaire].

Pneumologie (Stuttgart, Germany)·2018
Same journal

Pneumologie (Stuttgart, Germany)·2026
Same journal

Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations.

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Correction: Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Erratum: Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Acute lung failure].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[The internet as a source of information for patients with sarcoidosis].

Pneumologie (Stuttgart, Germany)·2026
See all related articles

The oral metabisulfite challenge can help diagnose sulfite-sensitive asthma. While not perfectly sensitive, it accurately identifies sensitivity in patients with asthma.

Area of Science:

  • Pulmonary Medicine
  • Allergy and Immunology
  • Clinical Diagnostics

Context:

  • Asthma patients may experience bronchoconstriction due to sulfite ingestion.
  • Accurate diagnosis of sulfite sensitivity is crucial for managing asthma triggers.
  • Existing diagnostic methods may have limitations in identifying sulfite sensitivity.

Purpose:

  • To evaluate the sensitivity and specificity of an oral provocation challenge using metabisulfite.
  • To determine the utility of the oral metabisulfite challenge in diagnosing sulfite-sensitive asthma.
  • To assess the diagnostic performance of the oral metabisulfite challenge in patients with asthma.

Summary:

  • An oral dose-response metabisulfite challenge was conducted in 44 patients with a history of sulfite-sensitive asthma, 27 asthma patients without sulfite sensitivity history, and 8 controls.

Related Experiment Videos

  • Airway response was measured by forced expiratory volume (FEV) decline 30 minutes after capsule ingestion.
  • Thirty-nine percent of patients with a history of sulfite-sensitive asthma showed significant bronchoconstriction; controls and non-sensitive asthma patients did not.

    • Impact:

    • The oral metabisulfite challenge demonstrates high specificity (100%) but low sensitivity (approximately 40%).
    • Despite its limitations, the oral metabisulfite challenge is a valuable diagnostic tool for sulfite-sensitive asthma, especially when patient history is uncertain.
    • This diagnostic approach aids in identifying specific triggers for asthma exacerbations, improving patient management.